Invention Grant
US08735412B2 Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine
有权
磺酰亚胺取代的苯胺基嘧啶衍生物作为CDK抑制剂，其制备及用作药物
- Patent Title: Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicine
- Patent Title (中): 磺酰亚胺取代的苯胺基嘧啶衍生物作为CDK抑制剂，其制备及用作药物
-
Application No.: US13125066Application Date: 2009-10-09
-
Publication No.: US08735412B2Publication Date: 2014-05-27
- Inventor: Ulrich Lücking , Rolf Jautelat , Gerhard Siemeister , Julia Schulze , Philip Lienau
- Applicant: Ulrich Lücking , Rolf Jautelat , Gerhard Siemeister , Julia Schulze , Philip Lienau
- Applicant Address: DE Monheim
- Assignee: Bayer Intellectual Property GmbH
- Current Assignee: Bayer Intellectual Property GmbH
- Current Assignee Address: DE Monheim
- Priority: EP08167113 20081021
- International Application: PCT/EP2009/007247 WO 20091009
- International Announcement: WO2010/046035 WO 20100429
- Main IPC: A61K31/505
- IPC: A61K31/505 ; C07D239/02
Abstract:
The invention relates to sulfoximine-substituted anilino-pyrimidine derivatives of formula (I). methods of production thereof, and use thereof as medication for the treatment of various diseases.
Public/Granted literature
Information query
